Antibody-Drug Conjugates: The New Frontier of Chemotherapy

In recent years, antibody-drug conjugates (ADCs) have become promising antitumor agents to be used as one of the tools in personalized cancer medicine. ADCs are comprised of a drug with cytotoxic activity cross-linked to a monoclonal antibody, targeting antigens expressed at higher levels on tumor c...

Descripción completa

Detalles Bibliográficos
Autores principales: Ponziani, Sara, Di Vittorio, Giulia, Pitari, Giuseppina, Cimini, Anna Maria, Ardini, Matteo, Gentile, Roberta, Iacobelli, Stefano, Sala, Gianluca, Capone, Emily, Flavell, David J., Ippoliti, Rodolfo, Giansanti, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7432430/
https://www.ncbi.nlm.nih.gov/pubmed/32752132
http://dx.doi.org/10.3390/ijms21155510

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7432430/
https://www.ncbi.nlm.nih.gov/pubmed/32752132
http://dx.doi.org/10.3390/ijms21155510

Ejemplares similares